Skip to main content

Table 5 Round 3 descriptive statistics

From: Clinical indicators to identify neuropathic pain in low back related leg pain: a modified Delphi study

Round 3 criteria for consensus include:
Median value of participants Likert scale data ≥ 4
IQR value of participants Likert scale data ≤ 1
Percentage of agreement 70% (Wiangkham et al., 2016 [25])
Clinical indicator Median IQR Percentage of agreement (%) Consensus achieved Ranking patient history indicators Ranking clinical examination indicators
Pain variously described as burning, electric shock like and/or shooting into leg 5 1 100 Yes 2  
Pain described as crawling or another unpleasant abnormal sensation (as a common example of dysesthesia) 4 1 90.3 Yes 4  
History of nerve injury, pathology or mechanical compromise at the region of the nerve root/or other nervous tissue around the lumbar spine that can refer into the leg 5 1 96.7% Yes 3  
In a patient with low back related leg pain does the pre-existing knowledge of metabolic (e.g. diabetes, vitamin deficiencies), hormonal (e.g. thyroid), genetic (e.g. channelopathies), pharmacological (antimetabolities), chemical (e.g. chemotherapy) conditions 3 1 48.5% No 7  
Pain in association with other neurological symptoms (e.g. pins and needles, numbness, weakness) 5 1 100% Yes 1  
Pain of high severity and irritability (i.e. easily provoked, taking longer to settle) 4 2 64.5% No 6  
Reports of spontaneous pain (i.e. stimulus independent) and/or paroxysmal pain (i.e. sudden recurrences and intensification of pain) 4 1 71.1% Yes 5  
Pain/symptom provocation with mechanical/movement tests (e.g. Active/Passive, Neurodynamic, i.e. SLR, Brachial plexus tension test) 4 1 67.8% No   3
Positive neurological signs (including altered reflexes, sensation and muscle power in dermatomal/myotomal or cutaneous nerve distribution) 5 1 90.4% Yes   1
Allodynia and/or hyperpathia within the distribution of pain 4 1 74.2% Yes   4
A loss of function of small fibre testing 4 1 77.4% Yes   2